Search research articles
Contact Us
Filters
Showing results (21-30 of 69) with videos related to
Page
of 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1991
N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 Gy by the Radiation Therapy Oncology Group
J D Cox, N Azarnia, R W Byhardt, et al.
Cancer
|
May 1, 1987
Brain metastasis in patients with superior sulcus tumors
R Komaki, S B Derus, C Perez-Tamayo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 15, 1993
A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07
R W Byhardt, T F Pajak, B Emami, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 20, 1993
The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)--analysis of a Radiation Therapy Oncology Group (RTOG) protocol
R W Byhardt, L Martin, T F Pajak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1990
A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11
J D Cox, N Azarnia, R W Byhardt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 15, 1995
Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09
K K Fu, M Clery, K K Ang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 1, 1994
Dose intensity of radiation therapy in non-small cell carcinoma of the lung: a review of RTOG data and strategies
J D Cox, W T Sause, R W Byhardt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 1982
Local control and survival after external irradiation for adenocarcinoma of the prostate
N Rangala, J D Cox, R W Byhardt, et al.
Cancer
|
June 1, 1992
Is long-term survival possible with external beam irradiation for stage D1 adenocarcinoma of the prostate?
C A Lawton, J D Cox, C Glisch, et al.
Cancer
|
April 1, 1985
Combined methotrexate and high-dose vincristine chemotherapy with radiation therapy for small cell bronchogenic carcinoma
P Y Holoye, J A Libnoch, T Anderson, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 69) with videos related to
Sort By:
Page
of 7
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1991
N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 Gy by the Radiation Therapy Oncology Group
J D Cox, N Azarnia, R W Byhardt, et al.
Cancer
|
May 1, 1987
Brain metastasis in patients with superior sulcus tumors
R Komaki, S B Derus, C Perez-Tamayo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 15, 1993
A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07
R W Byhardt, T F Pajak, B Emami, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 20, 1993
The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)--analysis of a Radiation Therapy Oncology Group (RTOG) protocol
R W Byhardt, L Martin, T F Pajak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1990
A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11
J D Cox, N Azarnia, R W Byhardt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 15, 1995
Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09
K K Fu, M Clery, K K Ang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 1, 1994
Dose intensity of radiation therapy in non-small cell carcinoma of the lung: a review of RTOG data and strategies
J D Cox, W T Sause, R W Byhardt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 1982
Local control and survival after external irradiation for adenocarcinoma of the prostate
N Rangala, J D Cox, R W Byhardt, et al.
Cancer
|
June 1, 1992
Is long-term survival possible with external beam irradiation for stage D1 adenocarcinoma of the prostate?
C A Lawton, J D Cox, C Glisch, et al.
Cancer
|
April 1, 1985
Combined methotrexate and high-dose vincristine chemotherapy with radiation therapy for small cell bronchogenic carcinoma
P Y Holoye, J A Libnoch, T Anderson, et al.
Page
of 7